Globe Newswire (Tue, 9-Dec 8:15 AM ET)
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Globe Newswire (Thu, 13-Nov 4:05 PM ET)
Globe Newswire (Thu, 6-Nov 8:00 AM ET)
Globe Newswire (Wed, 5-Nov 8:00 AM ET)
Globe Newswire (Tue, 28-Oct 8:00 AM ET)
Globe Newswire (Mon, 20-Oct 8:00 AM ET)
Market Chameleon (Tue, 14-Oct 5:53 AM ET)
Globe Newswire (Tue, 14-Oct 8:15 AM ET)
Market Chameleon (Tue, 23-Sep 5:54 AM ET)
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
Strata Skin Sciences trades on the NASDAQ stock market under the symbol SSKN.
As of January 9, 2026, SSKN stock price declined to $1.31 with 22,126 million shares trading.
SSKN has a beta of 0.66, meaning it tends to be less sensitive to market movements. SSKN has a correlation of 0.02 to the broad based SPY ETF.
SSKN has a market cap of $7.73 million. This is considered a Sub-Micro Cap stock.
Last quarter Strata Skin Sciences reported $7 million in Revenue and -$.36 earnings per share. This fell short of revenue expectation by $-788,000 and missed earnings estimates by -$.12.
In the last 3 years, SSKN traded as high as $13.90 and as low as $1.18.
The top ETF exchange traded funds that SSKN belongs to (by Net Assets): VXF.
SSKN has underperformed the market in the last year with a return of -57.2%, while the SPY ETF gained +19.0%. In the last 3 month period, SSKN fell short of the market, returning -24.1%, while SPY returned +3.7%. However, in the most recent 2 weeks SSKN has outperformed the stock market by returning +6.7%, while SPY returned +0.5%.
SSKN support price is $1.26 and resistance is $1.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SSKN shares will trade within this expected range on the day.
